1 long-form article and 0 pre-market mentions covering $ABBV from AskMelon Research.
Pfizer just printed a clean beat — $14.45 billion in Q1 2026 revenue, up 5.4%, an adjusted EPS of $0.75 that topped consensus, and management reaffirming full-year guidance of $59.5–62.5 billion. Read…